TRANSLATE

The mpn Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mpn Hub cannot guarantee the accuracy of translated content. The mpn and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The MPN Hub is an independent medical education platform, sponsored by AOP Health and GSK, and supported through an educational grant from Bristol Myers Squibb. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

How should conditioning be performed before transplanting a patient with MF?

Featured:

Craig W. FreyerCraig W. Freyer

Feb 18, 2021


During the 2021 TCT Meetings Digital Experience, the MPN Hub spoke to Craig W. Freyer, University of Pennsylvania, Philadelphia, US. We asked, How should conditioning be performed before transplanting a patient with MF?

How should conditioning be performed before transplanting a patient with MF?

Freyer overviews research on different conditioning regimens for patients with myelofibrosis (MF) prior to allogeneic stem cell transplant. This includes comparing outcomes and tolerability of myeloablative versus reduced intensity conditioning, finding the optimal treatment combination, and outlining early data for an intermediate intensity conditioning regimen.